Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001744975-18-000001
Filing Date
2018-07-02
Accepted
2018-07-02 20:51:39
Documents
1
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 4270
  Complete submission text file 0001744975-18-000001.txt   6338
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 702 SAN ANTONIO STREET AUSTIN TX 78701
Business Address 702 SAN ANTONIO STREET AUSTIN TX 78701 504-715-8335
Sibling Insiders Fund II L.P. (Reporting) CIK: 0001742552 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38558 | Film No.: 18934526

Mailing Address 702 SAN ANTONIO STREET AUSTIN TX 78701
Business Address 702 SAN ANTONIO STREET AUSTIN TX 78701 504-715-8335
Sibling Insiders II LLC (Reporting) CIK: 0001744975 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38558 | Film No.: 18934525